Lumos Diagnostics is striving to become the leader in rapid point-of-care tests to distinguish between viral and bacterial ...

Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins ...

Airtasker’s media-for-equity game is fuelling fast growth with minimal cash burn as the company expands into the UK and US.

With its Great White asset, Andromeda is circling the global kaolin market and several upcoming catalysts could see the stock re-rate.

Rare earths demand could be supercharged by the growth of the humanoid robot market. And it could leave magnet makers scrambling for supply.

Recruitment, property and content are ready for a technology reset, with Decidr quietly running the show in the background.

The ASX kept grinding higher on Tuesday morning, while MinRes jumped and DY6 lit up the boards with a massive gallium strike ...

Having overhauled Elon Musk’s Tesla as the biggest-selling maker of EVs, China’s BYD has revealed new charging technology.

NZ based wounds management house Aroa Biosurgery says the US tariff imposed on its products should be less than the general 10% Kiwi impost.

After revealing the presence of gallium at Tundulu REE and phosphate project, DY6 Metals has increased 340% to a daily high of 18.5c.

There were so many mining stocks reporting today we couldn't help but summarise, with gold, iron ore, coal and uranium all on the menu.

A surge in uranium stocks on the ASX today following whispers the mineral will be exempt from US tariffs has boosted the market 0.9pc.